Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1973 3
1974 2
1975 5
1976 7
1977 5
1978 1
1979 3
1980 2
1981 10
1982 13
1983 6
1984 7
1985 6
1986 3
1987 10
1989 3
1990 5
1991 2
1992 2
1993 2
1994 1
1995 3
1997 6
1998 1
1999 5
2000 5
2001 4
2002 2
2003 2
2004 4
2006 5
2007 5
2008 10
2009 7
2010 13
2011 12
2012 6
2013 5
2014 3
2015 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group; Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK. International Collaboration of Trialists, et al. J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502557 Free PMC article. Clinical Trial.
The hidden life of NAD+-consuming ectoenzymes in the endocrine system.
Malavasi F, Deaglio S, Zaccarello G, Horenstein AL, Chillemi A, Audrito V, Serra S, Gandione M, Zitella A, Tizzani A. Malavasi F, et al. Among authors: tizzani a. J Mol Endocrinol. 2010 Oct;45(4):183-91. doi: 10.1677/JME-10-0082. Epub 2010 Jul 21. J Mol Endocrinol. 2010. PMID: 20660167 Review.
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study.
Joniau S, Briganti A, Gontero P, Gandaglia G, Tosco L, Fieuws S, Tombal B, Marchioro G, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, Van Poppel H, Spahn M; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Among authors: tizzani a. Eur Urol. 2015 Jan;67(1):157-164. doi: 10.1016/j.eururo.2014.01.020. Epub 2014 Jan 25. Eur Urol. 2015. PMID: 24486307
Is there a prostate-specific antigen upper limit for radical prostatectomy?
Gontero P, Spahn M, Tombal B, Bader P, Hsu CY, Marchioro G, Frea B, Van Der Eeckt K, Kneitz B, Frohneberg D, Tizzani A, Van Poppel H, Joniau S. Gontero P, et al. Among authors: tizzani a. BJU Int. 2011 Oct;108(7):1093-100. doi: 10.1111/j.1464-410X.2011.10076.x. Epub 2011 Mar 10. BJU Int. 2011. PMID: 21392220
ERCC1 haplotypes modify bladder cancer risk: a case-control study.
Ricceri F, Guarrera S, Sacerdote C, Polidoro S, Allione A, Fontana D, Destefanis P, Tizzani A, Casetta G, Cucchiarale G, Vineis P, Matullo G. Ricceri F, et al. Among authors: tizzani a. DNA Repair (Amst). 2010 Feb 4;9(2):191-200. doi: 10.1016/j.dnarep.2009.12.002. Epub 2010 Jan 12. DNA Repair (Amst). 2010. PMID: 20061190
183 results